AzTrials
AzTrials

OrthodonticsRMGICNCT06602154

Comparison of Bond Failure with Resin-modified Glass Ionomer Cement and Visible Light-cure Composite Bonding Material in Adult Orthodontic Patients - a Split-Mouth, Randomized Controlled Trial

A study testing Resin modified glass ionomer in people with Orthodontics and Bracket Bonding, run by Aga Khan University Hospital, Pakistan at 2 sites in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this split mouth study design, 34 orthodontic patients coming for fixed appliance treatment will be bonded with standard light-cure composite bonding material and intervention of Resin Modified Glass Ionomer Cement (RMGIC). Read more about this study

Who is it for?
Ages 12 to 35 yearsHealthy volunteers can take part
What is being tested?
Resin modified glass ionomer
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
37 participants
Where
2 sitesPakistan
Study dates
1 Nov 2021to 20 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Patients aged between 12-35 years
  • Patients with fair to good oral hygiene who have no significant sign of gingivitis
  • Healthy patients with no co-morbids such as rheumatic fever, blood dyscrasias, congenital heart disease, or diabetes mellitus
  • Patients with class I, II and III malocclusions

Who cannot join

  • Enamel surface defects
  • Pregnant patients or lactating mothers
  • Syndromic patients
  • Subjects with previous history of orthodontic

Trial locations and contacts

2 sites in 1 country.

Pakistan2 sites
  • Aga Khan University Hospital

    Karachi, Sindh, 75500

  • Aga Khan University Hospital

    Karachi

Other trials in Pakistan

About this study

In this split mouth study design, 34 orthodontic patients coming for fixed appliance treatment will be bonded with standard light-cure composite bonding material and intervention of Resin Modified Glass Ionomer Cement (RMGIC). Contralateral quadrants will be allocated randomly for either RMGIC or visible light-cure composite bonding in both upper and lower jaw.

Quadrant 1: Randomly selected, contralateral upper and lower quadrants from central incisor to second premolar will be bonded with RMGIC bonding system.

Read more

Quadrant 2: Randomly selected, contralateral quadrants from central incisor to second premolar will be bonded with visible light-cure composite bonding material.

Allocation of diagonally opposite quadrants by either bonding system will be assigned randomly. Quadrants to be bonded with Resin-modified glass ionomer cement and light-cure composite bonding material will be switched from patient to patient to ensure randomization. This study is single blinded. The study investigators will not be blinded while the patient will be kept blinded.

On the first visit, a specially designed consent form will be signed by the participant.

Patient interaction for the purpose of study will only be for 1 hour duration while bonding of brackets. After six months amount and location of bond breakages will be evaluated from orthodontic record files.

This study will help us evaluate bond strength of RMGIC as compared to light cure composite. RMGIC can also be considered as the choice of material for bonding in high risk caries patients.

Read the detailed description

MATERIAL \& METHODS:

Study Design: Experimental study (Randomized Control Trial) Settings: Dental clinics, The Aga Khan University Hospital, Karachi (AKUH) Duration of Study: Patients will be recruited in this study for one and half hour. Chart analysis of these patients will then be done after six months of recruitment.

Sample Size:

Sample size was calculated with OpenEpi (version 3.01) sample size calculator using findings of Hegarty and Macfarlane14 who reported a bond failure percentage of 30% with light-cure adhesive and risk ratio of 2.6 (1.7, 3.9) for RMGIC as compared to resin based light cured composite. Keeping the above risk ratio at level of significance (α) 5% and power of study (1-β) 80%, at least 34 subjects were required for our study. The sample size will be inflated by 10% to account for sample attrition; therefore, a total of 37 subjects will be included in the study.

Sampling Technique: Non-probability consecutive sampling

Sample Selection:

Inclusion Criteria:

  • Patients aged between 18-35 years
  • Patients with fair to good oral hygiene who have no significant sign of gingivitis
  • Healthy patients with no co-morbids such as rheumatic fever, blood dyscrasias, congenital heart disease, or diabetes mellitus
  • Patients with class I, II and III malocclusions
  • All patients who will sign the consent form

Exclusion Criteria:

  • Enamel surface defects
  • Pregnant patients or lactating mothers
  • Syndromic patients
  • Subjects with previous history of orthodontic or functional appliance treatment

DATA COLLECTION PROCEDURE:

Data will be collected by well-organized proforma. (Annexure H) Ethical approval will be taken from the institutional Ethical Review Committee (ERC) before commencement of the study. All those patients who sign an informed consent form (Annexure I) will receive detailed information regarding the study.

Due to ethical considerations, only patients requiring fixed appliance orthodontic treatment will be recruited. In this split mouth study design, contralateral quadrants will be allocated randomly for either Resin-modified glass ionomer cement or visible light-cure composite bonding in both upper and lower jaw. Randomization as per annerxure J Quadrant 1: Randomly selected, contralateral upper and lower quadrants from central incisor to second premolar will be bonded with RMGIC bonding system.

Quadrant 2: Randomly selected, contralateral quadrants from central incisor to second premolar will be bonded with visible light-cure composite.

On the first visit, a specially designed consent form will be signed by the participant. The investigator will unseal the envelope from Clinical Trials Unit (CTU), containing information regarding the participants based on randomization.

Ethical considerations:

Study will be carried out as per guidelines of World Medical Association's Declaration of Helsinki and principles of GCP (Good Clinical Practice). Any modifications in the protocol will be re-submitted to the ERC. The trial will be conducted in compliance with regulations and a copy of the final study protocol will be submitted to ERC.

Consent:

After assessment of eligibility criteria, participants will be included in this study after signing consent form. Consent form will be explained to patient in a separate dental room by investigators to ensure privacy. If patient will be unable to decide then consent form will be given to patient and asked to reply after decision in 7 days. One copy of consent will be given to patient after signing and one copy will be kept with the investigators.

Being tested
Resin modified glass ionomer
Keywords
Resin-modified glass ionomer cement, Light cure composite, bracket bonding
Medical subject headings
Malocclusion, Anodontia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Resin modified glass ionomerOther

    The product will be stored by investigators at room temperature in lock and key.

    Product: Riva light cure RMGIC (HV) Composition: 18 mg orthodontic bonding paste and 6 ml enamel bond resin. Storage: Stored at room temperature and protected from humidity.

    Usage: Steps for Resin-modified glass ionomer cement composite bonding:

    1. Prepare all teeth with oil-free pumice, and rinse thoroughly for 15 seconds with water.
    2. Wash thoroughly.
    3. Etch enamel surface with 37% phosphoric acid for 15 seconds.
    4. Rinse the etched surface for 20 seconds to remove the acid and precipitates that might have formed during the etching procedure.
    5. Activate the capsule and immediately mix in an amalgamator. Do not click with applicator before you mix.
    6. Immediately place into capsule applicator and click trigger until paste is seen through the nozzle
    7. Light cure each increment for 20 seconds.
Study groups in NCT06602154
Study groupRoleWhat they receive
Control group ( light cure composite )Active comparatorProduct: Denturum Light Cure Band Adhesive (Ortho Organizers). Composition: 4 mg composite adhesive paste and 6 ml Transbond primer. Storage: Stored at room temperature and protected from humidity. Usage: Steps for light -cure composite bonding are: 1. Prepare teeth with oil-free pumice, and rinse thoroughly for 15 seconds with water. 2. Air dry tooth surface for 5 seconds until dry field is maintained and isolate with cotton rolls. 3. Etch enamel surface with 37% phosphoric acid for 15 seconds. 4. Rinse the etched surface for 20 seconds to remove the acid and precipitates that might have formed during the etching procedure. 5. Thoroughly dry etched surface with moisture free air. Tooth surface should appear frosty white, if not than reetch for 5 seconds. 6. Brush thin uniform amount of primer on every tooth surface. 7. Apply a small amount of adhesive paste onto bracket base and position the bracket on tooth surface. 8. After accurately placing bracket on tooth surfac
Receives: Other: Resin modified glass ionomer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bracket bond failure

    The objective of this study is to compare rate of bond failures with Resin-modified glass ionomer cement and visible light-cure bonding.

    Measured: Three months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2024
  2. Study start1 Nov 2021
  3. Primary completion20 Feb 2022
  4. Study completion20 Feb 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06602154
Sponsor's protocol ID
2022-5282-23281
Other IDs
Dr. Aleem Saeed Qureshi
Acronym
RMGIC
Status last verified
Sep 2024
First submitted
13 Sep 2024
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Qabool H, Qabool J, Sukhia RH, Fida M. Comparison of bond failure with resin-modified glass ionomer cement and visible light-cured composite bonding systems in orthodontic patients: A split-mouth randomized controlled trial. Dent Med Probl. 2024 Sep-Oct;61(5):651-657. doi: 10.17219/dmp/162970.

    PubMed 39364623

Questions about this trial

What is this clinical trial studying?

A study testing Resin modified glass ionomer in people with Orthodontics and Bracket Bonding, run by Aga Khan University Hospital, Pakistan at 2 sites in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bracket bond failure (time frame: Three months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06602154, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in